Novartis Poised To Grow Despite $9bn In LOEs Coming, CEO Says

 
• By Jessica Merrill
  
stairs growth
Novartis laid out a path for growth during an R&D day • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business